Navid Farzad

Navid Farzad joined as a partner with FCV in 2019 and became a managing partner in 2024. Mr. Farzad leads the Firm's investment team and is responsible for acquisition, divestiture, and providing unique value to the Fund's partnerships. Prior to FCV, Mr. Farzad was a partner with Morgan Noble Healthcare Partners, an investment firm exclusively focused on partnering with companies that are determined to transform the delivery of healthcare. Prior to Morgan Noble, Mr. Farzad was with Enhanced Healthcare Partners, a healthcare-focused private equity firm based in New York and has previously held positions with Lehman Brothers' healthcare investment banking division, Ernst & Young's Transaction Advisory group and Arthur Andersen's healthcare practice. 

Currently, Mr. Farzad serves as a director or observer on the boards of the Nashville Health Care Council, Praia Health, Thrive Health Tech, Lynx, Carta Healthcare, RightMove, Bicycle Health, DexCare, Vim, Oshi Health, Visana Health, Chamber Cardio, Aradigm and Qualified Health. He also serves on the board of the National Venture Capital Association (NVCA) and the advisory board of The Hilltop Institute, a research and data analytics organization dedicated to improving the health and wellbeing of communities. Mr. Farzad previously has been an investor in and/or served on the board of directors of Mindoula Health, Continuum Health, Captify Health, Privia Health and Trusted Health Plans. In recognition for his exceptional work in pushing innovation toward better healthcare for all, Mr. Farzad was named as a 2022 Top 50 in Digital Health honoree by Rock Health.

Please note that speakers provide their own biographies and headshots. Biographies represent the role of the person at the time of their engagement and are not independently verified by the Milken Institute.